Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades912
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions2
HIK
Media
HIK Company
Research
HIK Company
Timeline2
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
1,531.00
1.00 (0.07%)
Bid:
1,531.00
Ask:
1,532.00
Spread:
1.00 (0.065%)
Market Cap:
£3.22b
Last checked at -
Last checked at 
Intraday Hikma Pharmaceuticals Share Chart
Hikma Pharmaceuticals News
4 Sep 2020
LONDON MARKET MIDDAY: Stocks Rise As All Eyes Turn To US Jobs Report
LONDON MARKET MIDDAY: Stocks Rise As All Eyes Turn To US Jobs Report
4 Sep 2020
Barclays upgrades Hikma after US court ruling
(Sharecast News) - Barclays upgraded Hikma Pharmaceuticals to 'overweight' and increased its price target on the company's shares after a US court rul...
4 Sep 2020
UK BROKER RATINGS SUMMARY: Upgrades For Hikma And Imperial Brands
UK BROKER RATINGS SUMMARY: Upgrades For Hikma And Imperial Brands
4 Sep 2020
LONDON BRIEFING: Ryanair Raises Funds, Eyeing Post-Virus Opportunities
LONDON BRIEFING: Ryanair Raises Funds, Eyeing Post-Virus Opportunities
3 Sep 2020
US court of appeals upholds ruling in favour of Hikma over Vascepa
(Sharecast News) - US courts ruled against an appeal by Amarin related to Hikma Pharmaceuticals's generic treatment for heart conditions, Vascepa.
3 Sep 2020
Hikma Receives Favourable Court Ruling For Its Generic Vascepa
Hikma Receives Favourable Court Ruling For Its Generic Vascepa
17 Aug 2020
Ex-divs to take 7.7 points off FTSE 100 on 20 August
By Joice Alves LONDON, Aug 17 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no lo...
Follow the stocks
